Literature DB >> 14735342

Laparoscopic radiofrequency ablation of hepatic tumors: prospective clinical evaluation of ablation size comparing two treatment algorithms.

E Berber1, N L Herceg, K J Casto, A E Siperstein.   

Abstract

BACKGROUND: Radiofrequency ablation (RFA) is gaining increased acceptance for the local control of liver tumors. Essential for achieving local tumor control are reproducible volumes of ablation that encompass the tumor and a margin of normal liver parenchyma. The technical algorithm for performing ablations was arrived at in an animal model using normal liver. Limited amounts of data exist as to whether this translates to the human tumor model.
METHODS: We analyzed 531 ablated lesions in 154 patients undergoing laparoscopic RFA using RITA Medical Systems Starburst XL catheter deployed to a final diameter of 2-5 cm. The first 54 patients (algorithm 1) were treated with a larger initial deployment to 3 cm and incremental advancement of the catheter to the final diameter with a 20-min ablation time for a 5-cm lesion. The subsequent 100 patients (algorithm 2) were treated with a smaller initial deployment of 2 cm, incremental advancement to the final diameter, and 14-min total ablation time for a 5-cm lesion. Lesion size was measured on 1 week postablation CT scans. Analysis was performed using the two-tailed t-test.
RESULTS: Ablation zones tended to be larger with the second method. On 1 week postablation CT scans, mean +/- SEM lesion sizes created using the first and second algorithms were 3.7 +/- 0.1 cm vs 4.0 +/- 0.1 cm at 3 cm deployment ( p < 0.05); 4.3 +/- 0.1 cm vs 4.8 +/- 0.1 cm at 4 cm deployment ( p < 0.05), and 5.5 +/- 0.1 cm vs 5.6 +/- 0.2 cm at 5 cm deployment ( p > 0.05), respectively. The mean +/- SEM total ablation times for the first and second algorithms were 7.9 +/- 0.3 min vs 7.0 +/- 0.2 min at 3 cm deployment ( p < 0.05); 13.3 +/- 0.3 min vs 11.1 +/- 0.02 min at 4 cm deployment ( p < 0.05); and 27.8 +/- 1.2 min vs 21.4 +/- 1.2 min at 5 cm deployment ( p < 0.05), respectively. The small SEM values indicate little variation in lesion size.
CONCLUSIONS: These results show that both algorithms create dependable and reproducible zones of ablation, essential for reliable tumor destruction. Algorithm 2 demonstrates that creating an initial small core of ablation with rapid coagulation of the center of the lesion allows for equivalent, if not larger, final volumes to be performed in less time.

Entities:  

Mesh:

Year:  2004        PMID: 14735342     DOI: 10.1007/s00464-003-8911-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  8 in total

1.  The early histologic changes following electrocoagulation.

Authors:  W LOUNSBERRY; V GOLDSCHMIDT; C A LINKE; H J WALDER; D CHRZAN
Journal:  J Urol       Date:  1961-09       Impact factor: 7.450

2.  Hepatic ablation with use of radio-frequency electrocautery in the animal model.

Authors:  J P McGahan; J M Brock; H Tesluk; W Z Gu; P Schneider; P D Browning
Journal:  J Vasc Interv Radiol       Date:  1992-05       Impact factor: 3.464

Review 3.  The role of surgical resection of liver metastases in colorectal carcinoma.

Authors:  B Cady; M D Stone
Journal:  Semin Oncol       Date:  1991-08       Impact factor: 4.929

4.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

5.  Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations.

Authors:  A Siperstein; A Garland; K Engle; S Rogers; E Berber; A String; A Foroutani; T Ryan
Journal:  Surg Endosc       Date:  2000-04       Impact factor: 4.584

6.  Radiofrequency ablation lesions in a pig liver model.

Authors:  P D Hansen; S Rogers; C L Corless; L L Swanstrom; A E Siperstien
Journal:  J Surg Res       Date:  1999-11       Impact factor: 2.192

7.  Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.

Authors:  Eren Berber; Nora Flesher; Allan E Siperstein
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

8.  Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors.

Authors:  A Siperstein; A Garland; K Engle; S Rogers; E Berber; A Foroutani; A String; T Ryan; P Ituarte
Journal:  Ann Surg Oncol       Date:  2000-03       Impact factor: 5.344

  8 in total
  9 in total

1.  Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results.

Authors:  Paul F Laeseke; Lisa A Sampson; Dieter Haemmerich; Christopher L Brace; Jason P Fine; Tina M Frey; Thomas C Winter; Fred T Lee
Journal:  Radiology       Date:  2006-08-23       Impact factor: 11.105

2.  Which parameters are needed for targeting a multitined radiofrequency device--an approach to a simple algorithm.

Authors:  Dirk L Stippel; Christopher Bangard; Klaus Prenzel; Selim Yavuzyasar; Jürgen H Fischer; Arnulf H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2008-02-21       Impact factor: 3.445

3.  Comparison between different thickness umbrella-shaped expandable radiofrequency electrodes (SuperSlim and CoAccess): Experimental and clinical study.

Authors:  Masahiko Koda; Shiho Tokunaga; Tomomitsu Matono; Takaaki Sugihara; Takakazu Nagahara; Yoshikazu Murawaki
Journal:  Exp Ther Med       Date:  2011-09-01       Impact factor: 2.447

4.  Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience.

Authors:  Koray Karabulut; Federico Aucejo; Hizir Yakup Akyildiz; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2011-10-25       Impact factor: 4.584

5.  Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up.

Authors:  Naveen Ballem; Eren Berber; Tracy Pitt; Allan Siperstein
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

6.  Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.

Authors:  Nan He; Qian-Na Jin; Di Wang; Yi-Ming Yang; Yu-Lin Liu; Guo-Bin Wang; Kai-Xiong Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

7.  Histological, CT, and intraoperative ultrasound appearance of hepatic tumors previously treated by laparoscopic radiofrequency ablation.

Authors:  T Mason; E Berber; J C Graybill; A Siperstein
Journal:  J Gastrointest Surg       Date:  2007-07-25       Impact factor: 3.452

8.  Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis.

Authors:  Mingzhe Weng; Yong Zhang; Di Zhou; Yong Yang; Zhaohui Tang; Mingning Zhao; Zhiwei Quan; Wei Gong
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

9.  Pathologic correlation study of microwave coagulation therapy for hepatic malignancies using a three-ring probe.

Authors:  Perry Shen; Kim R Geisinger; Ronald Zagoria; Edward A Levine
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.